- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Spinal muscular atrophy (SMA)
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1954KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 1020KB)
Onasemnogene abeparvovec – November 2020
Onasemnogene abeparvovec: Solution for injection, customised based on patient weight; Zolgensma®
Last updated
19 March 2021